TABLE 1.
Serum characteristic (origin) | No. of samples with HHV-6 IgM
|
||
---|---|---|---|
Total | Acute phase | Only conv phasea | |
IgG seroconverted (Brazil) | 32 | 29 | 3 |
IgG increase (Brazil)b | 12 | 12 | NT |
IgG activity (Venezuela) | 37 | 22 | 12 |
Conv, convalescent-phase sera; NT, not tested.
HHV-6 IgG increase indicates an increase in band intensity of the convalescent-phase serum when compared to the acute-phase serum as previously described (2).